{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:10:18Z","timestamp":1792627818946,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thromres.2025.109317","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:33:50Z","timestamp":1743942830000},"page":"109317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study"],"prefix":"10.1016","volume":"249","author":[{"given":"Bauke","family":"Haisma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna R.","family":"Rijpma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"den Exter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmar C.","family":"Kruis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Nieuwenhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joline L.","family":"Saes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.A.","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waander L.","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia E.M.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.hoc.2021.07.011","article-title":"Disorders of fibrinogen and fibrinolysis","volume":"35","author":"May","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.thromres.2025.109317_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-030-58971-4_15","article-title":"Fibrinogen and Fibrin","volume":"96","author":"Litvinov","year":"2021","journal-title":"Subcell. Biochem."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0015","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/AOG.0b013e3181c2bde8","article-title":"Pregnancy and laboratory studies: a reference table for clinicians","volume":"114","author":"Abbassi-Ghanavati","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2025.109317_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv. Protein Chem."},{"issue":"12","key":"10.1016\/j.thromres.2025.109317_bb0025","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1172\/JCI26989","article-title":"Structure and function of the platelet integrin alphaIIbbeta3","volume":"115","author":"Bennett","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.thromres.2025.109317_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122711","article-title":"Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of A\u03b1, B\u03b2, and \u03b3 chains","volume":"18","author":"Paraboschi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.thromres.2025.109317_bb0035","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"Casini","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0029-1225758","article-title":"Congenital fibrinogen disorders","volume":"35","author":"de Moerloose","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109317_bb0045","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13296","article-title":"Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders","volume":"103","author":"Castaman","year":"2019","journal-title":"Eur. J. Haematol."},{"issue":"20","key":"10.1016\/j.thromres.2025.109317_bb0055","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"Saes","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/bloodadvances.2023012186","article-title":"Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the prospective rare bleeding disorders database","volume":"8","author":"Mohsenian","year":"2024","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"Lak","year":"1999","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mbc.0000224841.48463.be","article-title":"Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group","volume":"17","author":"Santacroce","year":"2006","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.transci.2004.04.003","article-title":"Pharmacokinetic properties of a pasteurised fibrinogen concentrate","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus. Apher. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2025.109317_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"van Geffen","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2025.109317_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109045","article-title":"Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: a comprehensive assessment","volume":"240","author":"Haisma","year":"2024","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2008.01894.x","article-title":"Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent","volume":"15","author":"Vijapurkar","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109317_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620912819","article-title":"Women with congenital hypofibrinogenemia\/afibrinogenemia: from birth to death","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0110","first-page":"519","article-title":"Congenital hypofibrinogenemia and recurrent placental abruption","volume":"61","author":"Ness","year":"1983","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109317_bb0115","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.ogx.0000143774.04144.b9","article-title":"Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature","volume":"59","author":"Frenkel","year":"2004","journal-title":"Obstet. Gynecol. Surv."},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jtha.2022.11.009","article-title":"High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study","volume":"21","author":"Maas","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/rth2.12300","article-title":"Pregnancy outcome in afibrinogenemia: are we giving enough fibrinogen concentrate? A case series","volume":"4","author":"Saes","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2000.01993.x","article-title":"Prenatal and peripartum management of congenital afibrinogenaemia","volume":"109","author":"Kobayashi","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/ejh.13941","article-title":"Management of rare inherited bleeding disorders: proposals of the French reference centre on haemophilia and rare coagulation disorders","volume":"110","author":"Trossaert","year":"2023","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jth.15652","article-title":"Treatment of patients with rare bleeding disorders in the Netherlands: real-life data from the RBiN study","volume":"20","author":"Maas","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109317_bb0150","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/trf.17029","article-title":"Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trials","volume":"62","author":"Khayat","year":"2022","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.thromres.2025.109317_bb0155","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/rth2.12433","article-title":"Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: observational study of efficacy and safety for prophylaxis and treatment","volume":"4","author":"Lasky","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-2516.2000.00448.x","article-title":"Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy","volume":"6","author":"Parameswaran","year":"2000","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/vox.12424","article-title":"Post-authorization safety study of Clottafact(\u00ae), a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study","volume":"111","author":"N\u00e9grier","year":"2016","journal-title":"Vox Sang."},{"issue":"9","key":"10.1016\/j.thromres.2025.109317_bb0170","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109317_bb0175","series-title":"Netherlands Hematology Society Guidelines for Rare Coagulation Factor Deficiencies","author":"Eikenboom","year":"2023"},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-3848(01)00247-X","article-title":"Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin","volume":"102","author":"Dupuy","year":"2001","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109317_bb0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00252836","article-title":"Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution","volume":"72","author":"Korte","year":"1994","journal-title":"Clin. Investig."},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0037-1613195","article-title":"Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I)","volume":"88","author":"de Bosch","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0195","first-page":"105","article-title":"Update on antithrombin I (fibrin)","volume":"98","author":"Mosesson","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders","volume":"44","author":"Korte","year":"2017","journal-title":"Transfus. Med. Hemother."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1160\/TH16-02-0082","article-title":"Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review","volume":"116","author":"Nagler","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109317_bb0210","series-title":"Williams Hematology, 9e","article-title":"Hereditary fibrinogen abnormalities","author":"Neerman-Arbez","year":"2015"},{"key":"10.1016\/j.thromres.2025.109317_bb0215","series-title":"Hemostasis and Thrombosis. Basic Principles and Clinical Practice","year":"2005"},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0220","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109317_bb0225","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.V97.6.1879","article-title":"Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T","volume":"97","author":"Attanasio","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0230","first-page":"149","article-title":"Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia","volume":"96","author":"Neerman-Arbez","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0235","article-title":"A case report of congenital afibrinogenemia and literature review of management of post-circumcision bleeding","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.thromres.2025.109317_bb0240","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2003-07-2316","article-title":"Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk)","volume":"103","author":"Lefebvre","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI5471","article-title":"Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia","volume":"103","author":"Neerman-Arbez","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.thromres.2025.109317_bb0250","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.ejhg.5201207","article-title":"Congenital afibrinogenaemia caused by uniparental isodisomy of chromosome 4 containing a novel 15-kb deletion involving fibrinogen Aalpha-chain gene","volume":"12","author":"Spena","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.thromres.2025.109317_bb0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MBC.0b013e328329f2a0","article-title":"A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream","volume":"20","author":"Robert-Ebadi","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0260","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/hae.12143","article-title":"Molecular basis of quantitative fibrinogen disorders in 27 patients from India","volume":"19","author":"Sumitha","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109317_bb0265","unstructured":"Wang H ZS, Yu X, Wu K, Zhao M, Zhu L. A single case gene mutation analysis of hypodysfibrinogenaemia associated with heterozygous mutation in fibrinogen \u03b1 Chain (IVS2+1G>T). J. Wezhou Medical University.54(7):598\u2013602."},{"issue":"8","key":"10.1016\/j.thromres.2025.109317_bb0270","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MBC.0000000000001260","article-title":"Fibrinogen A\u03b1 gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients","volume":"34","author":"Moazzeni","year":"2023","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102445","article-title":"Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families","volume":"8","author":"Tian","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"23","key":"10.1016\/j.thromres.2025.109317_bb0280","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","article-title":"Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia","volume":"55","author":"Zhou","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2025.109317_bb0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.12085","article-title":"Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia","volume":"160","author":"Shapiro","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MBC.0b013e328331e6db","article-title":"Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects","volume":"21","author":"Miesbach","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0300","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"Casini","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2025.109317_bb0305","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/00365513.2013.826818","article-title":"Dusart syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age","volume":"73","author":"Ramanathan","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0310","first-page":"235","article-title":"Erythrocyte hyperaggregation and thrombogenic dysfibrinogenemia","volume":"18","author":"Nguyen","year":"1998","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2004.08.003","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus. Apher. Sci."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2025.109317_bb0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00439-005-0102-0","article-title":"Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population","volume":"119","author":"Ko","year":"2006","journal-title":"Hum. Genet."},{"key":"10.1016\/j.thromres.2025.109317_bb0325","series-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","first-page":"693","article-title":"Afibrinogenemias and dysfibrinogenemias","author":"Galanakis","year":"2012"},{"key":"10.1016\/j.thromres.2025.109317_bb0330","series-title":"Hemostasis and Thrombosis Basic Principles and Clinical Practice","first-page":"855","article-title":"Dysfibrinogenemia and other disorders of fibrinogen structure or function","author":"McDonagh","year":"2001"},{"issue":"11","key":"10.1016\/j.thromres.2025.109317_bb0335","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.5858\/2002-126-1387-DAT","article-title":"Dysfibrinogenemia and thrombosis","volume":"126","author":"Hayes","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109317_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","article-title":"Fibrinogen and the risk of thrombosis","volume":"36","author":"de Moerloose","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109317_bb0350","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0038-1648947","article-title":"The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin","volume":"72","author":"Kumar","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109317_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0360","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1055\/s-0037-1615661","article-title":"Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions","volume":"85","author":"Remijn","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0365","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2516.2012.02759.x","article-title":"Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders","volume":"18","author":"Van Geffen","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109317_bb0370","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","article-title":"Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis","volume":"110","author":"Matsumoto","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109317_bb0375","series-title":"Physiology, Plasminogen Activation. StatPearls","author":"Katz","year":"2024"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T03:59:42Z","timestamp":1762228782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":75,"alternative-id":["S0049384825000660"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109317","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109317"}}